CYTOTOXICITY OF INHALABLE DRY POWDERS IN A549 HUMAN
LUNG CANCER CELL LINE
ANITA CHVATAL 1, RAMI ALZHRANI 2, AMIT K. TIWARI 2, RITA AMBRUS 1*, PIROSKA SZABÓ-RÉVÉSZ 1, SAI HS. BODDU 2
1University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Eötvös u. 6,
6720 Szeged, Hungary
2The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Frederic and Mary Wolfe Centre, Health
Science Campus, 3000 Arlington Avenue, MS 1013, 43614-2595 Toledo, OH, USA
*corresponding author: arita@pharm.u-szeged.hu
DownloadDownload Full Article

Abstract:
The aim of the present work was to study the cytotoxicity of meloxicam potassium (MP) containing dry powder inhalation
systems (DPIs) in monolayers of A549 lung epithelial cells, in order to acquire information on its suitability for pulmonary
drug delivery. We also characterized the effect of the used excipients (such as aerosolization enhancer additives and
polymers) on the cytotoxicity of the formulated DPIs. We reported for the first time the cytotoxicity of MP in comparison
with meloxicam (M) and the results showed that no difference in the safety can be determined at 0.01 and 0.1 mg/mL
concentrations. The protective effect of L-leucine was observed in some formulations, while the use of poly-vinyl-alcohol
(PVA) decreases this advantage. Comparing the two polymers it can be established that the poly-vinyl-pirrolidon (PVP) is
less toxic than the PVA in the same concentrations.






Top